It depends on the state
Inability to maintain adequate oral fluid intake due to these symptoms constitutes a medical concern requiring provider contact
Appetite becomes more predictable, emotional eating significantly decreases, and metabolic health continues to improve with ongoing support
These approaches include striking most-favored nation deals with GLP-1 manufacturers Novo Nordisk and Eli Lilly, providing access to discounted prices for GLP-1s through TrumpRx, and proposing to implement a new demonstration program called the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model to expand Medicare and Medicaid coverage of GLPs for obesity, which is currently subject to statutory limitations (prohibited in Medicare, permissible but not required in Medicaid)
Moreover, GLP-1 injections undergo rigorous FDA testing and require medical supervision , ensuring safety and efficacy that patches, sold as supplements, cannot match
It is important to follow the dosing schedule as set out by your prescriber